Literature DB >> 21352852

The ABC transporters in lipid flux and atherosclerosis.

Iryna Voloshyna1, Allison B Reiss.   

Abstract

Atherosclerotic cardiovascular disease is the leading cause of morbidity and mortality in the United States and in many other countries. Dysfunctional lipid homeostasis plays a central role in the initiation and progression of atherosclerotic lesions. The ATP-binding cassette (ABC) transporters are transmembrane proteins that hydrolyze ATP and use the energy to drive the transport of various molecules across cell membranes. Several ABC transporters play a pivotal role in lipid trafficking. They are critically involved in cholesterol and phospholipid efflux and reverse cholesterol transport (RCT), processes that maintain cellular cholesterol homeostasis and protect arteries from atherosclerosis. In this article we provide a review of the current literature on the biogenesis of ABC transporters and highlight their proposed functions in atheroprotection.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352852     DOI: 10.1016/j.plipres.2011.02.001

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  27 in total

1.  Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages.

Authors:  Iryna Voloshyna; Sony Modayil; Michael J Littlefield; Elise Belilos; Kristina Belostocki; Lois Bonetti; Gary Rosenblum; Steven E Carsons; Allison B Reiss
Journal:  Exp Biol Med (Maywood)       Date:  2013-09-02

2.  The ATP-binding cassette transporter-2 (ABCA2) regulates esterification of plasma membrane cholesterol by modulation of sphingolipid metabolism.

Authors:  Warren Davis
Journal:  Biochim Biophys Acta       Date:  2013-11-05

Review 3.  Regulation of foam cells by adenosine.

Authors:  Allison B Reiss; Bruce N Cronstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

Review 4.  Regulation of cerebral cholesterol metabolism in Alzheimer disease.

Authors:  Allison B Reiss; Iryna Voloshyna
Journal:  J Investig Med       Date:  2012-03       Impact factor: 2.895

Review 5.  Pleiotropic Anti-atherosclerotic Effects of PCSK9 InhibitorsFrom Molecular Biology to Clinical Translation.

Authors:  Angelos D Karagiannis; Martin Liu; Peter P Toth; Shijia Zhao; Devendra K Agrawal; Peter Libby; Yiannis S Chatzizisis
Journal:  Curr Atheroscler Rep       Date:  2018-03-10       Impact factor: 5.113

6.  Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction.

Authors:  Dario Degiorgio; Paola A Corsetto; Angela M Rizzo; Carla Colombo; Manuela Seia; Lucy Costantino; Gigliola Montorfano; Rossella Tomaiuolo; Domenico Bordo; Serena Sansanelli; Min Li; Daniela Tavian; Maria P Rastaldi; Domenico A Coviello
Journal:  Eur J Hum Genet       Date:  2013-09-18       Impact factor: 4.246

Review 7.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

8.  Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.

Authors:  Iryna Voloshyna; Isaac Teboul; Michael J Littlefield; Nicolle M Siegart; George K Turi; Melissa J Fazzari; Steven E Carsons; Joshua DeLeon; Allison B Reiss
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-27

Review 9.  High density lipoprotein biogenesis, cholesterol efflux, and immune cell function.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

Review 10.  Cholesterol Metabolism in CKD.

Authors:  Allison B Reiss; Iryna Voloshyna; Joshua De Leon; Nobuyuki Miyawaki; Joseph Mattana
Journal:  Am J Kidney Dis       Date:  2015-09-01       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.